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Abstract 
 
Cancer is one of the leading causes of death in the world, approximately 14 million 
new cases and 8.2 million deaths each year. Doxorubicin is a well-known chemotherapy drug 
which frequently used in treating various types of cancer. However,  doxorubicin posesses 
several side effects including cardiotoxic, hepatotoxic, nephrotoxic, and immunosuppression. 
One of the natural product that can be used as an adjuvant of doxorubicin to reduce the 
toxic effects is garlic chives (Allium tuberosum). The purpose of this study was to determine 
the effect of Allium tuberosum based on hematological profile, levels of CD4+, CD8+, and 
MDA serum of male Wistar rats which induced by doxorubicin. The hematological profile 
was analyzes by blood smear, levels of CD4+ and CD8+ were conducted by flowcytometry 
and levels of MDA serum were determined by spectrofotometry. The results showed that 
the etanolic extract of Allium tuberosum (EAT) increased neutrophil and lymphocyte, 
percentage of CD4+ cells (p<0.01) and CD8+ cells. It also decreased the levels of serum 
MDA (p<0.01). These results indicated that EAT work as immunostimulant possibly through 
an antioxidant mechanism (MDA). It can be concluded that EAT can be developed as adjuvant 
for doxorubicin. 
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INTRODUCTION 
 
Cancer appears as one of the major causes 
of death in the world. In 2012, there are 14 
million new cases and 8.2 million death caused 
by cancer (WHO, 2015). In Indonesia, the 
prevalence of cancer in 2013 is 1.4% and it is 
predicted that the amount of new case of cancer 
would be increased up to 70% in the next two 
decades (Kemenkes RI, 2015). The high 
prevalence and mortality of the cancer pushed to 
developed the effective therapy with the 
minimum side effect. 
Chemotherapy is still considered for 
treatment in cancer, and one of most frequently 
used is doxorubicin. Doxorubicin is antibiotic 
from tetracyclin class which widely used in 
treating various types of cancer such as breast, 
pulmonary, prostate, servics, and bone cancer 
(Li, et al., 2014), however treatment with 
doxorubicin for long term reveals several side 
effects including cardiotoxicity, hepatotoxicity, 
nephrotoxicity and immunosupression 
(Burridge, et al., 2016; Chaudhary, et al., 2016; 
Mohebbati, et al., 2016). Doxorubicin suppress 
the immune system by decreasing the  
expression level of IL-2, production of the γ-
interferon, natural killer (NK) cells, proliferation 
of lymphocytes, and rasio CD4+/CD8+ (Zhang, 
et al., 2005a). The pathway of lipid peroxidase is 
expected to be one of mechanisms causing 
oxidative stress from depletion of CD4+ (Gill, et 
al., 2003). Doxorubicin also increases BUN, 
creatinin, gout, SGOT, SGPT, and γ-GT 
(Roomi, et al., 2014). 
Co-chemotherapy is a strategy in cancer 
therapy by combining a potential compound 
with chemotherapy agent to increase the efficacy 
of therapy and also decrease the toxicity of 
chemotherapy agen (Zhang, et al., 2005b). One 
of the plants that has potensial is Bawang Kucai 
(Allium tuberosum). The leaf of bawang kucai 
contains flavonoids, specifically allicin which is 
proven to induce immune system by increasing 
the amount of CD4 (Feng, et al., 2012; Song and 
Choi, 2016), however the mechanism is still 
remains unclear. 
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Based on the explanation, Allium 
tuberosum has prospective potency to be used as 
co-chemotherapy with doxorubicin. This study 
is aimed to analyze whether the activity of 
Allium tuberosum as immunostimulant is 
through lipid peroxidase in doxorubicin-induced 
rats. 
 
MATERIALS AND METHODS 
 
Plants and Extract Preparation 
Bawang kucai (Allium tuberosum) leaves 
were collected from Malang, Indonesia on 
March 2016. The leaves were determined by 
Botanical Laboratory, Faculty of Mathematics 
and Science, Universitas Jember. Bawang kucai 
leaves were dried before powdered, resulting in 
total of 599 grams of kucai leaves powder were 
extracted by maceration using 70% ethanol with 
ratio of 1 : 3. Macerate was filtered using filter 
paper, then the filtrate was evaporated to collect 
viscous extract. Bawang kucai extract (BKE) 
then was administrated to animals in this study. 
 
Animals Preparation 
As many as 37 male Wistar rats weighted 
90-150 grams were used in this study. The 
animals were grouped and housed in cages at 
temperature and humidity-controlled room (25-
32
o
C and 98% relative humidity) and given free 
access to food and water. The animals were 
given time to adapt with laboratory condition for 
7 days. The rats then divided into five groups, 
each groups consisted of 6-7 rats. 
 
In vivo Experimental Design 
Before being treated (D0), all rats were 
adapted for 1 week. The entire groups were 
given a different treatment for 14 days as 
follows: 1) Normal control group (0.9% NaCl 
i.p); 2) Negative control group (4.67 mg/kgBW 
doxorubicin in 0.5% CMC-Na p.o); 3) Extract 
control group (1000 mg/kgBW of EAT 
dissolved in 0.5% CMC-Na); 4) Treatment A 
group (4.67 mg/kgBW doxorubicin i.p + 500 
mg/kgBW BKE p.o); 5) Treatment B group 
(4.67 mg/kgBW doxorubicin i.p + 1000 
mg/kgBW BKE p.o). Doxorubicin induction was 
done on the day-1 (D1) and day-8 (D8). All 
groups were treated daily for 14 days. On 15th 
day, the blood were collected from oculary 
before necropsied to isolate spleen for analysis. 
 
Calculation of  White Blood Cells  
Extraction of blood for leukocytes level 
was collected via oculary venous of all rats on 
the day-15. White blood cells (leukocytes, 
lymphocytes and neutrophils) were observed 
through blood films that smeared on the object 
glass  using microscope 1000x magnification. 
 
The determination of CD4+ and CD8+ 
concentration 
The percentage of TCD4+ and TCD8+ 
cells from the spleen were analyzed by 
flowcytometry. The rats were anasthetized by 
chloroform before surgery and the spleen was 
taken. The spleen was put into petri dish filled 
with 2 mL of cell staining buffer, then crushed 
slowly. The cells were moved into a tube and 
centrifugated in 5 minutes on 5000 rpm and 
40°C, then added with red blood cell lysis buffer 
and PBS twice. The suspension was stained with 
FITC anti mouse CD4 and PE anti mouse CD8 
in cell staining buffer with ratio 1 : 1000. The 
data was analyzed by BD FACS Calibur on Cell 
QuestPro mode. 
 
The determination of MDA Serum 
Concentration 
Briefly, 100 µL blood serum and BHT 10 
µL liquid were mixed in glass tube. 
Consecutively, 700 µL orthophosphoric acid 1 
% and 200 µL 2-thiobarbituric acid (TBA) 0.6% 
were added in tube then incubated into 
waterbath filled by hot water 95°C for  45 
minutes. After incubation, the tube was chilled 
in the cold water. 1 µL n-butanol was added into 
tube, then centrifugated in 2000 rpm for 10 
minutes. The top layer was taken and the 
absorbance was determined by 
spectrophotometer in λ 535 nm. TBARS 
(Thiobarbituric Acid Reactive Substance) is a 
MDA bioproduct  that condensed with TBA, 
calculated in  µM using coefficient extinction 1, 
56 x 105 M
-1
 cm-
1
. 
 
RESULT AND DISCUSSION 
 
Thin Layer Chromatography Profile 
The TLC system consist of silica F254 
as stationary phase and butanol, acetic acid, dan 
aquadest (8 : 2 : 10) as mobile phase. The result 
showed EAT contain flavonoid as its compound 
(Fig. 1). 
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Figure 1 . Result of EAT TLC’s Test 
 
 
Effect EAT on Hematologic Profile 
(Lymphocyte and Neutrophil) 
Intraperitoneal administration of 
doxorubicin could reduce the percentage of 
lymphocytes compare with control group, but 
did not affect the percentage of neutrophils 
(Table 1). Meanwhile, EAT treatment against 
Doxorubicin-induced group could increase the 
percentage of lymphocytes and neutrophiles. 
Based on the dose given, EAT 500 mg/kgBB is 
better in increasing lymphocytes percentages, 
while EAT 1000 mg/kgBB is better in 
increasing the neutrophiles percentages. 
Effect EAT againts CD4 + and CD8 + 
cells 
 Potency of EAT as immunostimulant 
also confirmed by analysis flowcytometri about 
the percentage of CD4+ and CD8+ (Fig. 2). 
Treatment of EAT on doxorubicin induced 
group showed an increase in CD4+ cells were 
significantly (p<0.01) compared to those 
induced doxorubicin alone , either at a dose of 
500 or 1000 mg/kg (Table 1) . The combination 
also able to increase the percentage of CD8+ 
cells.  
 
 
 
Table 1. Effect of EAT on levels of lymphocytes , neutrophils , the percentage of CD4+ , CD8+ , and 
the ratio of CD4+ / CD8+ 
 
 
a p<0,01 dibandingkan dengan Control group 
b p<0,05 dibandingkan dengan DOX group. 
 
 
 
 
Group 
lymphocytes 
(%) 
neutrophils 
(%) 
CD4+ (%) CD8+ (%) 
Ratio 
CD4+/CD8+ 
Control 37.20 ± 7.46 40.60 ± 11.52 20.13 ± 6.46 14.81 ± 2.18 1.43 ± 0.64 
DOX 30.80 ± 6.18 40.20 ± 6.38 11.73 ± 1.02 12.72 ± 2.53 0.96 ± 0.27a 
EAT 1000 45.60 ± 3.51 49.00 ± 5.70 35.65 ± 1.93a 17.15 ± 6.44 2.48 ± 0.41 
DOX + EAT 500 41.40 ± 6.73 45.40 ± 6.95 22.95 ± 6.09b 15.79 ± 12.93 1.47 ± 0.18 
DOX + EAT 1000 38.48 ± 7.30 48.40 ± 9.24 28.69 ± 4.65b 17.61 ± 2.29 1.66 ± 0.43 
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Figure 2. Effect ethanolic extract of Allium tuberosum (EAT ) against the percentage of CD4 and 
CD8’s male Wistar rats. The histogram shows the distribution of CD4+ T cells (r2) and the 
distribution of CD8+ cells (r4) on : (A) Normal Control without treatment, (B) doxorubicin, (C) EAT 
Controls 1000 mg/kg, (D) A combination of doxorubicin and EAT 500 mg/kg, and (E) A combination of 
doxorubicin and EAT 1000 mg/kg. 
 
 
 
3.4 Effect of EAT Againts MDA serum 
levels  
 
To confirm the repair mechanism of 
immune system pathways were measured 
MDA levels. MDA is used as an indicator of 
an reorganize by lipid peroxidation. MDA 
increased indicate oxidation processes or 
membrane damage caused by free radicals. 
Fig. 3 shows the doxorubicin increase the 
MDA serum levels were significantly 
(p<0.01). Meanwhile, EAT administration 
after induction by Doxorubicin can lower 
MDA serum levels were significantly (p<0.05 
at a dose of 500 mg /kg and p< 0.01 at a dose 
of 1000 mg/kg body weight). 
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Figure 3. Effect of EAT on MDA serum levels 
 
Doxorubicin had chemotherapeutic 
effect that classified as an anthracycline class. 
The chemotherapeutic agents most often chosen 
and most effective since 1970 (Alessandra, et 
al., 2007). Doxorubicin is used for the various 
types of cancer such as breast, lung, prostate, 
cervical, bone, etc. (Li, et al., 2014). 
Doxorubicin is not selective, it is affect not only 
cancer cells but also normal cells that divide 
actively. As a result of the non-selective affect, 
doxorubicin also affect the formation of cells 
that are actively dividing cells such as bone 
marrow, lymphocytes, hair, and various organ 
toxicities (Tacar, et al., 2012). 
In this study, EAT restore immune 
function previously suppressed by doxorubicin. 
Induction doxorubicin dose 4.67 mg/kg on the 
first day and 8 show a significant effect in 
reducing the immune cells, it is accordance 
with the results of the study (2011). In the 
previous studies, doxorubicin induction on the 
first day and the fourth day, the treatment give a 
significan effect to reduction CD4+. While the 
immunostimulatory effect of EAT indicated by 
an increased proliferation of lymphocytes, 
neutrophils and increased CD8+ cytotoxic T-
cells and CD4+ T helper cells, this effect is due 
to the flavonoid on EAT. Flavonoids are able to 
increase the number of CD4+ significantly 
according research Chauhan, et al. (2010). In 
contrast to this, in this study EAT increase 
CD8+ but not significant because of the content 
of other compounds that are immuno-
suppressive in EAT as steroids or terpenoids 
(Zhang, et al., 2009). 
MDA levels measurement was 
conducted to confirm mechanism of action of 
EAT as immunostimulant. MDA was used as 
an indicator of a recast by lipid peroxidation. 
The effects of doxorubicin toxicity possible due 
to oxidative stress. This study shows that the 
induction of doxorubicin significantly increases 
serum MDA levels. After EAT administration, 
MDA decreased which indicated lipid 
peroksidase pathway played a role in the 
mechanism of immunosuppression. 
Based on the data, we can conclude that 
doxorubicin causes immunosuppression. EAT 
at the dose of 1000 mg/kg after induction of 
doxorubicin able to restore the immune system 
significantly by increased antioxidant activity. 
 
REFERENCES 
 
Alessandra, L., Stefano, F., Gaetano, B.and 
Salvatore S., 2007., Long-term Follow-
Up of Patients with Doxorubicin-
induced Cardiac Toxicity After 
Chemotherapy for Osteosarcoma, Anti 
Cancer Drugs, 18(6), 737-744. 
Chaudhary, D., Khatiwada, S., Sah, S.K.,Tamang 
M.K., Bhattacharya S. and Jha C.B., 2016, 
Effect of Doxorubicin on 
Histomorphology of Liver of Wistar 
Albino Rats, J. Pharm. Pharmacol., 
4(2016), 186-190.   
Chirumbolo, S., 2010, The Role of Quercetin, 
Flavonols and Flavones in Modulating 
Inflammatory Cell Function, Inflamm. 
Allergy Drug Targets, 9(4), 263-85.  
Feng, Y., Zhu, X., Wang, Q., Jiang, Y., Shang, 
H., Cu, L., et al., 2012, Allicin Enhances 
Host Pro-inflammatory Immune 
Responses and Protects Against Acute 
murine malaria infection, Malar. J., 11(1), 
268-276.   
Information: 
* ) p<0.01 compared with control group 
  ** ) p<0.05 compared with DOX group 
*** ) p<0.01 compared with DOX group 
 
Sutejo, et al., 2017 
Indones. J. Cancer Chemoprevent., 7(3), 93-98  
 
98 
 
 
Gill, L., Martinez, G., Gonzalez, I., Tarinas,A., 
Alvarez, A., Giuliani, A., et al., 2003. 
Contribution to Characterization of 
Oxidative Stress in HIV/AIDS Patients, 
Pharmacol. Res., 47(3), 217-224.  
Kasianningsih, S., Rivanti, E., Pratama, 
R.H.,Pratama, N.R., Ikawati, M. and 
Meiyanto, E., 2011., Taraxacum officinale 
Leaves Etanolikic Extract as 
Immunostimulatory Agent for Reducing 
Side Effect of Doxorubicin in Sprague 
Dawley Rats, Indones. J. of Cancer 
Chemoprevent., 2(1), 135-140.  
Kementrian Kesehatan RI, 2015, SituasiPenyakit 
Kanker, Jakarta: Pusatdata dan informasi 
Kementrian Kesehatan RI. 
Li. M., Tang, Z., Lv, S., Song, W., Hong, H.,Jing, 
X., et al., 2014, Cisplatin Crosslinked pH 
Sensitive Nanoparticles for Efficient 
Deliveryof Doxorubicin, Biomaterials, 
35(12), 3851-3864.   
Mohebbati, R., Abbsnezhad, A., Khajavi,R.A., 
Mousavi, S.M. and Haghshenas M., 2016, 
Effect of HydroalcholicExtract of Nigella 
sativa on Doxorubicin-Induced 
Functional Damage of Kidney in Rats, 
Horizon Med. Sci., 22(1), 13-20.   
Roomi, W., Kalinovsky, T., Roomi, N.W.,Rath, 
W. and Niedzwiecki, A., 2014, 
Prevention of Adriamycin-induced 
Hepatic and Renal Toxicity in Male 
BALB/c Mice by a Nutrient Mixture, Exp. 
Ther. Med., 7(4),1040–1044.   
Song, W.Y. and Choi J.H., 2016, Effects of 
Oenanthe javanica and Allium 
tuberosum on Lipid Content in Rats Fed 
a High-fat High-cholesterol Diet, J. Life 
Sci., 26(3), 302-308.   
Tacar, O., Sriamornsak, P. and Dass, C.R., 
2012, Doxorubicin: An Update 
onAnticancer Molecular Action, 
Toxicityand Novel Drug Delivery 
Systems, J. Pharm. Pharmacol., 65(2), 157-
170.   
World Health Organization, 2015, Cancer, 
http://www.who.int/mediacentre/factshe
ets/fs297/en/, Cited June 8, 2016. 
Zhang, F., Zhang, X., Wang, B.C. and Wang,F., 
2009, Pachymic Acid, A Novel 
Compound for Anti-Rejection: Effect in 
Rats Following Cardiac Allograft 
Transplantation, Chin. Med. J., 122(23), 
2898-2902.  
Zhang, X., Li, W., Wu, Y., Zheng, T., Li, 
W.,Qu, S., et al., 2005b, 
Proanthocyanidin from Grape Seeds 
Potentiates Anti-tumor Activity of 
Doxorubicin via Immunomodulatory 
Mechanism, Int. Immunopharmacol., 5(7-
8), 1247-1257.   
Zhang, X.Y., Li, W.G., Wu, Y.J. and Gao, M.T., 
2005a, Amelioration of Doxorubicin-
Induced Myocardial Oxidative Stress and 
Immuosuppression by Grape Seed 
Proanthocyanidins in Tumour-bearing 
Mice, J. Pharm. Pharmacol., 57(8), 1043-
1051.   
 
 
